BioVie Inc. shares are traded on Nasdaq, and MarketBeat reported its average stock rating.
6 reports, 3 independent
Updated Sep 8
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 6
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioVie Inc. shares are traded on Nasdaq, and MarketBeat reported its average stock rating.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- MarketBeat's screener tool lists BioVie as a penny stock.Sub-event
BioVie advanced its pipeline through trials in North America.1 source
BioVie Inc. shares are traded on Nasdaq and received a stock rating report.1 source
Keep exploring
The entities involved
-
Biovie
French company founded in 2007, specializing in online sales of organic, raw, and living foods, committed to education on healthy eating.
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- MarketBeat reported the stock average rating for Range Capital Acquisition Corp., a company that trades on the Nasdaq exchange.
- MarketBeat provides stock rating data for Vivos Therapeutics, which is listed on Nasdaq.
- AbbVie is listed on the Nasdaq stock exchange, and MarketBeat is reporting on its stock performance.
- Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.